RVMD Stock Price
RVMD
RVMD stock price is $186.89 (+5.20% on the day), giving RVMD a market cap of $42.80B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
RVMD Stock Overview
- Price
- $186.89
- Previous close
- $177.65
- Open
- $184.87
- Market cap
- $42.80B
- 1-year price target
- $252.96
- MarketXLS Rank
- 55
About RVMD
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline includes RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; and RMC-5552, which is in phase 1 clinical trial. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RVMD | $186.89 | +5.2% | 1.22M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |